Press Releases

Date	Title	PDF Version
Feb 04, 2021	Alexion Reports Fourth Quarter and Full Year 2020 Results
Jan 25, 2021	Alexion to Report Fourth Quarter and Full Year 2020 Results on Thursday, February 4, 2021
Jan 13, 2021	Alexion Provides Update on Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19
Jan 12, 2021	Alexion Highlights Commercial, Clinical and Financial Progress at the 39th Annual J.P. Morgan Healthcare Conference
Jan 05, 2021	Alexion to Present at the 39th Annual J.P. Morgan Healthcare Conference
Dec 12, 2020	AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial Development
Nov 20, 2020	Alexion Receives Marketing Authorization from European Commission for New Formulation of ULTOMIRIS® (ravulizumab) with Significantly Reduced Infusion Time
Nov 10, 2020	Alexion to Present at Upcoming Virtual Investor Conferences
Nov 04, 2020	Caelum and Alexion Announce Upcoming Data Presentations at the 62nd American Society of Hematology Annual Meeting and Exposition
Nov 04, 2020	Alexion Announces Upcoming Data Presentations at the 62nd American Society of Hematology Annual Meeting and Exposition

Search